Lipoic acid plays a role in scleroderma: insights obtained from scleroderma dermal fibroblasts |
| |
Authors: | Pei-Suen Tsou Beatrix Balogh Adam J Pinney George Zakhem Ann Lozier M Asif Amin William A Stinson Elena Schiopu Dinesh Khanna David A Fox Alisa E Koch |
| |
Institution: | .Scleroderma Program, University of Michigan, 300 North Ingalls St. 7C27 NIB, Ann Arbor, MI 48109 USA ;.University of Michigan Medical School, University of Michigan Medical School, 109 Zina Pitcher Pl, 4388 BSRB, Ann Arbor, MI 48109 USA ;.Division of Rheumatology, Department of Internal Medicine, University of Michigan Medical School, 300 North Ingalls St. 7C27 NIB, Ann Arbor, MI 48109 USA ;.Department of Medical Affairs, VA Medical Service, 2215 Fuller Rd., Ann Arbor, MI 48105 USA |
| |
Abstract: | IntroductionSystemic sclerosis (SSc) is a connective tissue disease characterized by fibrosis of the skin and organs. Increase in oxidative stress and platelet-derived growth factor receptor (PDGFR) activation promote type I collagen (Col I) production, leading to fibrosis in SSc. Lipoic acid (LA) and its active metabolite dihydrolipoic acid (DHLA) are naturally occurring thiols that act as cofactors and antioxidants and are produced by lipoic acid synthetase (LIAS). Our goals in this study were to examine whether LA and LIAS were deficient in SSc patients and to determine the effect of DHLA on the phenotype of SSc dermal fibroblasts. N-acetylcysteine (NAC), a commonly used thiol antioxidant, was included as a comparison.MethodsDermal fibroblasts were isolated from healthy subjects and patients with diffuse cutaneous SSc. Matrix metalloproteinase (MMPs), tissue inhibitors of MMPs (TIMP), plasminogen activator inhibitor 1 (PAI-1) and LIAS were measured by enzyme-linked immunosorbent assay. The expression of Col I was measured by immunofluorescence, hydroxyproline assay and quantitative PCR. PDGFR phosphorylation and α-smooth muscle actin (αSMA) were measured by Western blotting. Student’s t-tests were performed for statistical analysis, and P-values less than 0.05 with two-tailed analysis were considered statistically significant.ResultsThe expression of LA and LIAS in SSc dermal fibroblasts was lower than normal fibroblasts; however, LIAS was significantly higher in SSc plasma and appeared to be released from monocytes. DHLA lowered cellular oxidative stress and decreased PDGFR phosphorylation, Col I, PAI-1 and αSMA expression in SSc dermal fibroblasts. It also restored the activities of phosphatases that inactivated the PDGFR. SSc fibroblasts produced lower levels of MMP-1 and MMP-3, and DHLA increased them. In contrast, TIMP-1 levels were higher in SSc, but DHLA had a minimal effect. Both DHLA and NAC increased MMP-1 activity when SSc cells were stimulated with PDGF. In general, DHLA showed better efficacy than NAC in most cases.ConclusionsDHLA acts not only as an antioxidant but also as an antifibrotic because it has the ability to reverse the profibrotic phenotype of SSc dermal fibroblasts. Our study suggests that thiol antioxidants, including NAC, LA, or DHLA, could be beneficial for patients with SSc.Electronic supplementary materialThe online version of this article (doi:10.1186/s13075-014-0411-6) contains supplementary material, which is available to authorized users. |
| |
Keywords: | |
|
|